Patent infringement actions filed by King Pharmaceuticals, Inc.
Against Teva Pharmaceutical Industries and Intelliject, Inc.
relating to EpiPen are ongoing.
King brought patent-infringement actions against Sandoz in the U.S
District Court…
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.